{"nct_id":"NCT06105632","title":"A Study to Learn About the Study Medicine Called PF-07220060 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-08","start_date":"2024-01-09","start_date_type":"ACTUAL","primary_completion_date":"2025-09-26","primary_completion_date_type":"ESTIMATED","completion_date":"2028-01-21","completion_date_type":"ESTIMATED","phases":["PHASE2"],"tickers":["PFE"]}